Journal of Oral Health and Community Dentistry

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  17 (2023)
Volume  16 (2022)
Volume  15 (2021)
Volume  14 (2020)
Volume  13 (2019)
Volume  12 (2018)
Volume  11 (2017)
Volume  10 (2016)
Volume  9 (2015)
Volume  8 (2014)
Volume  7 (2013)
Volume  6 (2012)
Volume  5 (2011)
Volume  4 (2010)
Volume  3 (2009)
Volume  2 (2008)
Volume  1 (2007)
Related articles

VOLUME 6 , ISSUE 1 ( January-April, 2012 ) > List of Articles

CASE REPORT

Cyclosporine and Amlodipine Induced Severe Gingival Overgrowth - Etiopathogenesis and Management of a Case with Electrocautery and Carbon-Dioxide(CO2) Laser

Rashmi Hegde, Rahul Kale, A Sanjay Jain

Citation Information : Hegde R, Kale R, Jain AS. Cyclosporine and Amlodipine Induced Severe Gingival Overgrowth - Etiopathogenesis and Management of a Case with Electrocautery and Carbon-Dioxide(CO2) Laser. J Oral Health Comm Dent 2012; 6 (1):34-42.

DOI: 10.5005/johcd-6-1-34

License: NA

Published Online: 01-09-2015

Copyright Statement:  NA


Abstract

Gingival overgrowth is a well recognized, unwanted side-effect associated with three major drugs/drug groups – phenytoin, cyclosporine and the calcium channel blockers. Cyclosporine is a potent immunosuppressive compound that has been used increasingly in conjunction with kidney, heart and other transplants. Calcium channel blockers are widely used in medical practice for the management of cardiovascular disorders. Due to their wide range of use, gingival overgrowth is now a recognized side-effect associated with them. Here we discuss a case report dealing with severe gingival overgrowth induced by cyclosporine and amlodipine. A 36-year-old man who underwent renal transplant came with a chief complaint of generalized gingival swelling. He had very severe gingival overgrowth in both arches and required thorough scaling and oral hygiene instructions, followed by supportive periodontal therapy for 4 months, after which radical gingivectomy using electrocautery and CO2 laser was performed. The post operative results were excellent and there was no recurrence at 1 year follow-up.

PDF Share
  1. Risk factors for drug-induced gingival overgrowth. Journal of Clinical Periodontology 2000;27:217–23.
  2. Calcium channel blocker-induced gingival hyperplasia: case report and review of this iatrogenic disease. J Fam Practice 1994;39:483–88.
  3. Nifedipine-induced gingival overgrowth. Ann Pharmacother 1997;31:935.
  4. Nifedipine induced gingival hyperplasia: A histochemical and ultrastructural study. J Periodontal 1985;56:211–15.
  5. Toxicological evaluation of cyclosporine- A. Arch Toxicol 1983;52:107–41.
  6. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 1984;223:1362–67.
  7. Treatment of intra-ocular infiammatory disease with cyclosporine-A. Lancet 1983;2:235–38.
  8. Cyclosporine in Behcet's disease (letter). Lancet 1983;2:454.
  9. J Periodontol 1984;55:708–12.
  10. Cyclosporine relieves arthralgia, causes angiodema (letter). A' Engl J Med 1980;303:754.
  11. Androgen metabolism in gingival hyperplasia induced by nifedipine and cyclosporine. J Periodont Res 1990;25;25–30.
  12. Initial observation that cyclosporine-A induces gingival enlargement in man. Journal of Clinical Periodontology 1983;10:237–46.
  13. Studies on the mechanism of action of cyclosporine-A. (Proceedings). Br J Pharmacol 1979;66:66–67.
  14. “Amlodipine induced gingival overgrowth.” Journal of Clinical Periodontology 1994;21:281–83.
  15. Drug-induced gingival overgrowth in organ transplant patients PhD. Newcastle Upon Tyne 1995.
  16. Cyclosporine, nifedipine, and gingival hyperplasia [letter]. Lancet 1987;2:739.
  17. The prevalence and severity of cyclosporine and nifedipine-induced gingival overgrowth. Journal of Clinical Periodontology 1993;20:37–40.
  18. The pathogenesis of drug-induced gingival overgrowth [review]. Journal of Clinical Periodontology 1996;23:165–75.
  19. Nifedipine pharmacological variables as risk factors for gingival overgrowth in organ-transplant patients. Clinical Oral Investigations 1997;1:35–39.
  20. Iatrogenic gingival overgrowth in cardiac transplantation. Journal of Periodontology 1995;66:742–46.
  21. Biological effects of cyclosporine A: A new antilymphocyte agent. Agents and Actions 1976;6:468–75.
  22. Cyclosporine A: pharmacokinetics after a single dose in man and serum levels after multiple dosing in recipients of allogenic bone marrow grafts. Current Therapeutics Research 1981;30:5.
  23. Cyclosporine A - usefulness, risks and mechanisms of action. Immunologicai Review 1982;65:5–22.
  24. Cyclosporine and the gingival tissues. J Clin Periodontol 1992;19:1–11.
  25. The effect of cyclosporine A on Tlymphocyte subpopulations. In: Cyclosporine A, ed, D, J, G, White, pp, 1982;209–32, Elsevier, Amsterdam.
  26. Mechanism of action of cyclosporine: a unifying hypothesis. Advances in Experimental Medicine and Biology 1987;213:309–330.
  27. Development of phenytoin induced gingival overgrowth in non-institutionalized epileptic children subjected to different plaque control programs. Acta Odontologica Scandinavica 1987;45:81–85.
  28. The effect of plaque control programme on the incidence and severity of cyclosporine induced gingival changes. Journal of Clinical Periodontology 1991;18:107–10.
  29. Regulation of human gingival fibroblast growth and synthetic activity by cyclosporine A in vitro. Journal of Periodontal Research 1989;24:314–21.
  30. Gingival hyperplasia induced by cyclosporine A. British Dental Journal 1984;157:305–309.
  31. Gingival enlargement: A comparison between cyclosporine and azathioprine treated renal allograft recipients, Swedish Dental Journal 1986;10:85–92.
  32. Amlodipine Induced Gingival Hyperplasia: J Oral Health Comm Dent 2007;1(1):19–22.
  33. Diphenylhydantion (Dilantin) gingival hyperplasia; Drug-induced abnormality of connective tissue. Proc Natl Acad Sci (USA) 1976;73:2909–12.
  34. Regulation cyclosporine A. J Periodontol 1998;69:899–910.
  35. Synergistic enhancement of collegenous protein synthesis by human gingival fibroblasts exposed to nifedipine and interleukin-1-beta in vitro. J Oral Pathol Med 2000;29:8–12.
  36. Cyclosporine A upregulates interleukin-6 gene expression in human gingiva: Possible mechanism for gingival overgrowth. J Periodontol 1994;11:552–60.
  37. Evidence for production of an inactive collagenase by fibroblasts from phenytion-enlarged human gingiva. J Oral Pathol 1982;11:310–17.
  38. Prevention and treatment consideration in patients with drug-induced gingival enlargement. Curr Opin Periodontol 1997;4:59–63.
  39. A dental protocol for the pediatric cardiac transplant patient. ASDC J Dent Child 1986;53:382–85.
  40. Periodontal management of gingival overgrowth in the heart transplant patient: A case report. J Periodontal 1997;68:1140–46.
  41. A clinical review of drud-induced gingival overgrowth. Oral Surg Oral Med Oral Pathol 1993;76:543–48.
  42. Effectiveness of periodontal treatments on cyclosporine induced gingival overgrowth in transplant patients. Br Dent J 1997;183:89–94.
  43. Nifedipine aggravates cyclosporine A-induced hyperplasia. Pediatr Nephrol 1994;8:181.
  44. Dental plaque-induced gingival disease Annals of Periodontology 1999;4:7–17.
  45. A critical review of drug induced gingival overgrowth. Australian Dental Journal 1999;44:219–32.
  46. Role of fibroblast subpopulations in periodontal physiology and pathology. Journal Periodontal Research 1991;26:144–54.
  47. The effect of a plaque control programme on the incidence and severity of cyclosporininduced gingival changes. Journal of Clinical Periodontology 1991; 18:107–10.
  48. Drug-induced overgrowth: Old problem, new problem. Critical Reviews in Oral Biology and Medicine 1991;2:103–37.
  49. Iperplasia gingivale da nifedipina: Fattori predisponenti (Gingival hyperplasia caused by nifedipine: Predisposing factors). Mondo Odontosmatol 1987;4:41–44.
  50. Gingival hyperplasia caused by nifedipine-a preliminary report. Int J Cardiol 1984;4:195–204.
  51. The management of drug induced gingival overgrowth. J Clin Periodontol 2006;33:434–39.
  52. A comparison of mucosal incisions made by scalpel, CO2 laser, electrocautery, and constant-voltage electrocautery. Otolaryngol Head Neck Surgery 1997;116:379–85.
  53. Electrosurgery-a biological approach. Journal of Clinical Periodontology 1987;14:557–63.
  54. Treatment of phenytoin-induced gingival hyperplasia by electrosurgery. Journal of Oral Surgery 1980;38:306–11.
  55. Surgical treatment of cyclosporine A-and nifedipine-induced gingival enlargement: gingivectomy versus periodontal flap. Journal of Periodontology 1998;69:791–97.
  56. Present and future of lasers in oral soft tissue surgery: clinical applications. Journal of Clinical Laser Medicine and Surgery 1996;14:179–84.
  57. Combined treatment approach to gingival overgrowth due to drug therapy. Journal of Clinical Periodontology 1996;23:941–44.
  58. The efficacy of three different surgical techniques in the management of drug-induced gingival overgrowth. J Clin Periodontol 2006;33:677–82.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.